| 摘要 |
The invention applies to obtaining new chemicals, namely, obtaining (2-morpholinophenyl) guanidine or its pharmaceutically eligible salts.<IMAGE>where-NR1R2 is N-methylamino-, N,N-dimethylamino-, N-ethylamino-, N-ethyl-N-methylamino-, N-butylamino-, N-methoxyethyl-N-methylamino, N-alyl-N-methylamino-, N-ethyl-N-methoxyethyl-amino-, N,N-dialylamino-, N-methylpiperazinyl-, dimethylmorpholino-, methylpiperidino-, morpholino-, or tiomorpholino groups, andR3 designates hydrogen, fluorine, chlorine atoms, and methyl- or methoxy- groups.The mentioned chemicals possess hypoglycaemic properties, and they may be used as anti-diabetic medications. The aim of the invention is to obtain new (2-morpholinophenyl) guanidines, which would possess a new type biological effect for this chemical group.
|
